MOLECULAR THERAPY, published by CELL PRESS, is a distinguished journal in the field of molecular biology and therapy, renowned for its significant contributions to drug discovery, genetics, and pharmacology since its inception in 2000. This prestigious journal, which holds a commendable position in the Q1 category across multiple disciplines including Drug Discovery, Molecular Medicine, and Molecular Biology, facilitates cutting-edge research and innovative therapies that aim to improve patient outcomes. With an impressive Scopus ranking that places it among the top journals in its field—such as rank #6 in Drug Discovery and #8 in Pharmacology—MOLECULAR THERAPY is crucial for researchers, professionals, and students seeking to advance their understanding and application of molecular techniques. The journal welcomes high-quality submissions that explore the therapeutic potential of molecular mechanisms, fostering a collaborative spirit within the scientific community to push the boundaries of modern medicine.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION is a premier publication dedicated to the advancements in the fields of clinical biochemistry, nutrition, and dietary sciences. Published by the esteemed JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION in Japan, this journal serves as a crucial platform for researchers and professionals to disseminate their findings and insights. With an ISSN of 0912-0009 and an E-ISSN of 1880-5086, it features a broad spectrum of original research articles, reviews, and case studies, fostering a deeper understanding of the interplay between biochemical processes and nutritional science. Notably, the journal has achieved significant rankings, placed in the Q3 and Q2 quartiles across various relevant categories, indicating its rising impact and relevance within the scientific community. Researchers will benefit from its rich repository of knowledge, while students and professionals will find it an invaluable resource for staying updated with the latest developments. Access options are available for interested readers, further contributing to the journal's objective of promoting open dialogue and research in clinical biochemistry and nutrition.

FREE RADICAL RESEARCH, published by TAYLOR & FRANCIS LTD, stands at the forefront of studies in biochemistry and medicine, with a distinguished trajectory since its inception in 1985. This esteemed journal, which boasts an ISSN of 1071-5762 and an E-ISSN of 1029-2470, is recognized for its impactful contributions within the scientific community, as evidenced by its Q2 ranking in the 2023 category quartiles for both Biochemistry and miscellaneous Medicine. Utilizing rigorous peer-review standards, FREE RADICAL RESEARCH disseminates critical findings on the role of free radicals in biological systems, facilitating knowledge exchange among researchers, healthcare professionals, and students. Although it is not an open-access journal, its reach through academic databases ensures visibility and accessibility of groundbreaking research, making it an indispensable resource for those engaged in the dynamic fields of biochemistry and molecular biology. As the journal continues to evolve until 2024, it remains committed to advancing our understanding of oxidative stress and its implications for health and disease.

ANTIOXIDANTS & REDOX SIGNALING, published by MARY ANN LIEBERT, INC, is a premier journal dedicated to advancing the understanding of oxidative stress, antioxidants, and redox biology in various health contexts. With an impressive track record since its inception in 1999, this journal has continually evolved, currently converging towards 2024 as a core resource for researchers in biochemistry, cell biology, and molecular medicine. It holds a distinguished position in Q1 across several categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, reflecting its critical role in disseminating high-quality research that impacts the fields of physiology and medicine. Despite not being an open-access journal, ANTIOXIDANTS & REDOX SIGNALING is renowned for its rigorous peer-review process and wide reach, ensuring that published articles are both influential and accessible to professionals, academia, and students alike. Researchers can benefit from its comprehensive articles that delve into cutting-edge discoveries and emerging therapies related to oxidative stress and its biological implications.

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

CHEMICO-BIOLOGICAL INTERACTIONS is a premier journal published by Elsevier Ireland Ltd, dedicated to advancing the field of chemical and biological interactions since its inception in 1969. With a robust focus on pharmacology and toxicology, the journal holds a prestigious Q1 ranking in both Medicine (miscellaneous) and Toxicology, reflecting its significance in disseminating influential research. As part of the Scopus database, it ranks #21 out of 133 journals in Toxicology, positioning it in the 84th percentile and ensuring high visibility for cutting-edge studies. This scholarly platform serves as a crucial resource for researchers, professionals, and students who seek reliable and innovative findings at the intersection of chemistry and biology. While currently not open access, CHEMICO-BIOLOGICAL INTERACTIONS provides a comprehensive collection of articles that contribute to the ongoing dialogue in toxin research and its implications on medicinal chemistry, thereby fostering advancements in public health and safety.

Redox Biology, published by Elsevier, stands as a premier open-access journal in the fields of biochemistry, clinical biochemistry, and organic chemistry. Since its inception in 2013, the journal has provided a vibrant platform for researchers to disseminate high-quality findings that advance our understanding of redox biology and its implications in health and disease. With an impressive impact factor and ranked Q1 across multiple chemistry disciplines, Redox Biology is recognized for its significant contributions to the scientific community, drawing attention from a global audience. This journal aims to foster a rich dialogue among scientists, clinicians, and students, emphasizing the critical role of redox processes in biological systems. Located in the Netherlands, Redox Biology has become an essential resource for those seeking to explore the nuanced interactions of reactive species and their roles in cellular function and pathology, making it a must-read for anyone interested in the forefront of biochemistry research.

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

BIOFACTORS, an esteemed journal published by Wiley, serves as a pivotal resource in the fields of Biochemistry, Clinical Biochemistry, and Molecular Medicine. With ISSN 0951-6433 and E-ISSN 1872-8081, the journal has established its reputation since its inception in 1988, showcasing a rich history of scientific inquiry and innovation. Recognized for its high academic standards, it currently holds a Q1 ranking in key categories, including Biochemistry and Medicine (miscellaneous), and ranks in the top 10% for Clinical Biochemistry according to Scopus metrics, reflecting its impact and influence in the scientific community. Although it does not offer Open Access, BIOFACTORS provides researchers the opportunity to publish and disseminate high-quality studies that advance our understanding of biological factors and their clinical implications. The journal actively encourages contributions that bridge the gap between laboratory findings and clinical applications, making it a vital platform for both seasoned researchers and emerging scholars in the life sciences.

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.